Get App Open
In App
Lending
Lending
Open App
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 10, 16:01
1130.00 11.05 (0.99%)
Volume
AVERAGE VOLUME
5-Day
35,658
10-Day
30,655
30-Day
77,859
40,031
  • Prev. Close

    1118.95

  • Open Price

    1125.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 10, 15:56
1130.30 10.40 (0.93%)
Volume
AVERAGE VOLUME
5-Day
1,566,320
10-Day
1,491,859
30-Day
1,431,831
1,455,177
  • Prev. Close

    1119.90

  • Open Price

    1125.40

  • Bid Price (Qty.)

    1130.30 (523)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Aurobindo Pharma (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 8,167.75 7,208.39 5,497.31 4,301.88 4,178.31  
Less: Excise/Sevice Tax/Other Levies 149.74 158.82 144.40 97.28 96.87  
Revenue From Operations [Net] 8,018.01 7,049.57 5,352.91 4,204.60 4,081.44  
Total Operating Revenues 8,095.10 7,110.71 5,425.10 4,281.45 4,133.12  
Other Income 67.22 74.80 26.51 19.06 57.01  
Total Revenue 8,162.32 7,185.51 5,451.61 4,300.51 4,190.13  
EXPENSES  
Cost Of Materials Consumed 3,920.33 3,422.34 3,053.64 2,393.29 2,328.63  
Purchase Of Stock-In Trade 15.76 96.89 78.09 35.52 8.53  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -159.09 -35.75 -121.08 89.87 -136.38  
Employee Benefit Expenses 668.75 514.21 431.42 364.10 303.60  
Finance Costs 132.14 288.84 250.06 267.58 55.02  
Depreciation And Amortisation Expenses 245.15 185.97 171.39 142.94 125.04  
Other Expenses 1,398.93 1,193.55 1,024.97 825.17 671.53  
Total Expenses 6,221.97 5,666.05 4,888.49 4,118.47 3,355.97  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,940.35 1,519.46 563.12 182.04 834.16  
Exceptional Items 0.00 0.00 0.00 -319.86 -28.71  
Profit/Loss Before Tax 1,940.35 1,519.46 563.12 -137.82 805.45  
Tax Expenses-Continued Operations  
Current Tax 420.63 334.62 126.50 4.87 183.75  
Less: MAT Credit Entitlement 9.95 124.56 126.50 0.00 0.00  
Deferred Tax 13.32 137.31 64.15 -118.03 26.75  
Tax For Earlier Years 0.00 0.00 2.98 17.95 1.15  
Total Tax Expenses 424.00 347.37 67.13 -95.21 211.65  
Profit/Loss After Tax And Before ExtraOrdinary Items 1,516.35 1,172.09 495.99 -42.61 593.80  
Profit/Loss From Continuing Operations 1,516.35 1,172.09 495.99 -42.61 593.80  
Profit/Loss For The Period 1,516.35 1,172.09 495.99 -42.61 593.80  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 52.01 40.24 17.04 -1.46 20.63  
Diluted EPS (Rs.) 51.97 40.20 17.02 -1.46 18.56  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 2,153.63 2,020.71 1,822.98 1,455.40 1,521.95  
Indigenous Raw Materials 1,766.70 1,401.62 1,230.66 937.89 806.68  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 9.77 4.73 3.58 3.62 6.21  
Indigenous Stores And Spares 106.20 71.00 57.24 60.84 48.29  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 131.28 87.41 43.68 29.11 58.72  
Tax On Dividend 25.04 14.85 7.20 4.72 9.64  
Equity Dividend Rate (%) 300.00 300.00 150.00 100.00 200.00  
Source : Dion Global Solutions Limited

Results of Aurobindo Pharm